Nordberg Medical AB is based in Sweden and belongs to the medical technology sector. The MedTech company, which is active in the European market, specializes in biotechnological production processes and the commercialization of state-of-the-art and future-oriented biomaterials. Based on 15 years of worldclass R&D by its parent company SinoBiom, Nordberg Medical has outstanding know-how and unique capabilities in the development of novel biotechnologies. Nordberg Medical offers revolutionary biofunctionalized materials that can be used in a variety of medical fields, such as Aesthetics, Dermatology, Orthopedics, Surgery and Sports Medicine. The first product to be offered in Europe in the near future is Juläine™, an injectable new generation Poly-L-Lactic Acid (PLLA) which activates natural collagen production in the skin. The product, like all other future products from Nordberg Medical, will be produced in Sweden.